These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 19180663

  • 41. New bioabsorbable septal repair implant for percutaneous closure of a patent foramen ovale: short-term results of a single-centre experience.
    Van den Branden BJ, Post MC, Jaarsma W, ten Berg JM, Suttorp MJ.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):286-90. PubMed ID: 19213063
    [Abstract] [Full Text] [Related]

  • 42. Patent foramen ovale closure with the Gore septal occluder: initial UK experience.
    Thomson JD, Hildick-Smith D, Clift P, Morgan G, Daniels M, Henderson R, Spence MS, Mahadevan VS, Crossland D, Ormerod O.
    Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):467-73. PubMed ID: 23766247
    [Abstract] [Full Text] [Related]

  • 43. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L, Infantino V, Orzan F, Vicentini S, Rovera C, Longo G, Chinaglia A, Belli R, Allais G, Gaita F.
    J Cardiol; 2014 Nov 15; 64(5):390-4. PubMed ID: 24713153
    [Abstract] [Full Text] [Related]

  • 44. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y, Zhang X, Zhang F.
    J Cardiothorac Surg; 2020 Jan 09; 15(1):11. PubMed ID: 31918738
    [Abstract] [Full Text] [Related]

  • 45. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G, Dell'Avvocata F, Giordan M, Braggion G, Aggio S, Chinaglia M, Roncon L, Cardaioli P, Chen JP.
    J Interv Cardiol; 2009 Aug 09; 22(4):398-403. PubMed ID: 19515082
    [Abstract] [Full Text] [Related]

  • 46. [Migraine, stroke and patent foramen ovale--connected or not?].
    Vuković V, Aleksić-Shihabi A, Lovrencić-Huzjan A, Demarin V.
    Acta Med Croatica; 2008 May 09; 62(2):197-203. PubMed ID: 18710084
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Transcatheter closure of patent foramen ovale associated with atrial septal aneurysm with Amplatzer Cribriform septal occluder.
    Musto C, Cifarelli A, Pandolfi C, De Felice F, Fiorilli R, Caferri G, Violini R.
    J Invasive Cardiol; 2009 Jun 09; 21(6):290-3. PubMed ID: 19494408
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
    Musto C, Cifarelli A, Fiorilli R, De Felice F, Parma A, Pandolfi C, Confessore P, Bernardi L, Violini R.
    J Invasive Cardiol; 2012 Oct 09; 24(10):510-4. PubMed ID: 23043034
    [Abstract] [Full Text] [Related]

  • 51. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug 09; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 52. Residual shunting after percutaneous PFO closure: how to manage and how to close.
    Butera G, Sarabia JF, Saracino A, Chessa M, Piazza L, Carminati M.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):950-8. PubMed ID: 23804551
    [Abstract] [Full Text] [Related]

  • 53. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 15; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 54. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
    Ponnuthurai FA, van Gaal WJ, Burchell A, Mitchell A, Wilson N, Ormerod O.
    Heart Lung Circ; 2009 Apr 15; 18(2):140-2. PubMed ID: 18294910
    [Abstract] [Full Text] [Related]

  • 55. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
    Zajarias A, Thanigaraj S, Lasala J, Perez J.
    J Invasive Cardiol; 2006 Nov 15; 18(11):533-7. PubMed ID: 17090816
    [Abstract] [Full Text] [Related]

  • 56. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients.
    Wahl A, Praz F, Stinimann J, Windecker S, Seiler C, Nedeltchev K, Mattle HP, Meier B.
    Swiss Med Wkly; 2008 Oct 04; 138(39-40):567-72. PubMed ID: 18853285
    [Abstract] [Full Text] [Related]

  • 57. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
    Sorensen SG, Aguilar H, McKnight WK, Thomas H, Muhlestein JB.
    J Interv Cardiol; 2010 Dec 04; 23(6):575-80. PubMed ID: 20796165
    [Abstract] [Full Text] [Related]

  • 58. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J, Bertog SC, Franke J, Steinberg DH, Majunke N, Wilson N, Wunderlich N, Sievert H.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):541-6. PubMed ID: 22707325
    [Abstract] [Full Text] [Related]

  • 59. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Araszkiewicz A, Sławek S, Trojnarska O, Lesiak M, Grygier M.
    Catheter Cardiovasc Interv; 2018 Jul 01; 92(1):159-164. PubMed ID: 29068141
    [Abstract] [Full Text] [Related]

  • 60. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS, Richter C, Otto J, Himmrich L, Schnabel R, Kampmann C, Rupprecht HJ, Marx J, Hommel G, Münzel T, Horstick G.
    Int J Cardiol; 2009 May 01; 134(1):33-41. PubMed ID: 18715659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.